Atlas Trials

Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)

Clinical trial NCT03333057 · COMPLETED

Trial details

NCT number
NCT03333057
Sponsor
Novaliq GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye Disease (DED)
Start date
2018-01-03
Primary completion
2018-05-18
Enrollment
336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.